Published Erratum
doi: 10.1038/s42255-020-0201-1.
Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission
Stephan Sachs #
1
2
3
4
, Aimée Bastidas-Ponce #
1
4
5
6
, Sophie Tritschler #
1
4
7
8
, Mostafa Bakhti
1
4
5
, Anika Böttcher
1
4
5
, Miguel A Sánchez-Garrido
2
, Marta Tarquis-Medina
1
4
5
6
, Maximilian Kleinert
2
9
, Katrin Fischer
2
3
, Sigrid Jall
2
3
, Alexandra Harger
2
, Erik Bader
1
, Sara Roscioni
1
, Siegfried Ussar
4
6
10
, Annette Feuchtinger
11
, Burcak Yesildag
12
, Aparna Neelakandhan
12
, Christine B Jensen
13
, Marion Cornu
13
, Bin Yang
14
, Brian Finan
14
, Richard D DiMarchi
14
15
, Matthias H Tschöp
2
3
4
, Fabian J Theis
16
17
18
, Susanna M Hofmann
19
20
21
, Timo D Müller
22
23
24
, Heiko Lickert
25
26
27
28
Affiliations
Affiliations
- 1 Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
- 2 Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
- 3 Division of Metabolic Diseases, Department of Medicine, Technical University of Munich, Munich, Germany.
- 4 German Center for Diabetes Research (DZD), Neuherberg, Germany.
- 5 Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany.
- 6 Department of Medicine, Technical University of Munich, Munich, Germany.
- 7 Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany.
- 8 School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
- 9 Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
- 10 RG Adipocytes & Metabolism, Institute for Diabetes & Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
- 11 Research Unit Analytical Pathology, Helmholtz Center Munich, Neuherberg, Germany.
- 12 InSphero AG, Schlieren, Switzerland.
- 13 Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
- 14 Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
- 15 Department of Chemistry, Indiana University, Bloomington, IN, USA.
- 16 Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany. fabian.theis@helmholtz-muenchen.de.
- 17 School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. fabian.theis@helmholtz-muenchen.de.
- 18 Department of Mathematics, Technical University of Munich, Munich, Germany. fabian.theis@helmholtz-muenchen.de.
- 19 Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.
- 20 German Center for Diabetes Research (DZD), Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.
- 21 Medical Clinic and Polyclinic IV, Ludwig Maximilian University of Munich, Munich, Germany. susanna.hofmann@helmholtz-muenchen.de.
- 22 Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.
- 23 German Center for Diabetes Research (DZD), Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.
- 24 Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. timo.mueller@helmholtz-muenchen.de.
- 25 Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.
- 26 German Center for Diabetes Research (DZD), Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.
- 27 Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.
- 28 Department of Medicine, Technical University of Munich, Munich, Germany. heiko.lickert@helmholtz-muenchen.de.
# Contributed equally.
- PMID: 33820985
- DOI: 10.1038/s42255-020-0201-1
Item in Clipboard
Published Erratum
Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission
Stephan Sachs et al.
Nat Metab.
2020 Apr.
Display options
Format
doi: 10.1038/s42255-020-0201-1.
Authors
Stephan Sachs #
1
2
3
4
, Aimée Bastidas-Ponce #
1
4
5
6
, Sophie Tritschler #
1
4
7
8
, Mostafa Bakhti
1
4
5
, Anika Böttcher
1
4
5
, Miguel A Sánchez-Garrido
2
, Marta Tarquis-Medina
1
4
5
6
, Maximilian Kleinert
2
9
, Katrin Fischer
2
3
, Sigrid Jall
2
3
, Alexandra Harger
2
, Erik Bader
1
, Sara Roscioni
1
, Siegfried Ussar
4
6
10
, Annette Feuchtinger
11
, Burcak Yesildag
12
, Aparna Neelakandhan
12
, Christine B Jensen
13
, Marion Cornu
13
, Bin Yang
14
, Brian Finan
14
, Richard D DiMarchi
14
15
, Matthias H Tschöp
2
3
4
, Fabian J Theis
16
17
18
, Susanna M Hofmann
19
20
21
, Timo D Müller
22
23
24
, Heiko Lickert
25
26
27
28
Affiliations
- 1 Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
- 2 Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
- 3 Division of Metabolic Diseases, Department of Medicine, Technical University of Munich, Munich, Germany.
- 4 German Center for Diabetes Research (DZD), Neuherberg, Germany.
- 5 Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany.
- 6 Department of Medicine, Technical University of Munich, Munich, Germany.
- 7 Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany.
- 8 School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
- 9 Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
- 10 RG Adipocytes & Metabolism, Institute for Diabetes & Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
- 11 Research Unit Analytical Pathology, Helmholtz Center Munich, Neuherberg, Germany.
- 12 InSphero AG, Schlieren, Switzerland.
- 13 Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
- 14 Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
- 15 Department of Chemistry, Indiana University, Bloomington, IN, USA.
- 16 Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany. fabian.theis@helmholtz-muenchen.de.
- 17 School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. fabian.theis@helmholtz-muenchen.de.
- 18 Department of Mathematics, Technical University of Munich, Munich, Germany. fabian.theis@helmholtz-muenchen.de.
- 19 Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.
- 20 German Center for Diabetes Research (DZD), Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.
- 21 Medical Clinic and Polyclinic IV, Ludwig Maximilian University of Munich, Munich, Germany. susanna.hofmann@helmholtz-muenchen.de.
- 22 Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.
- 23 German Center for Diabetes Research (DZD), Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.
- 24 Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. timo.mueller@helmholtz-muenchen.de.
- 25 Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.
- 26 German Center for Diabetes Research (DZD), Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.
- 27 Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.
- 28 Department of Medicine, Technical University of Munich, Munich, Germany. heiko.lickert@helmholtz-muenchen.de.
# Contributed equally.
- PMID: 33820985
- DOI: 10.1038/s42255-020-0201-1
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
Targeted pharmacological therapy restores β-cell function for diabetes remission.Sachs S, Bastidas-Ponce A, Tritschler S, Bakhti M, Böttcher A, Sánchez-Garrido MA, Tarquis-Medina M, Kleinert M, Fischer K, Jall S, Harger A, Bader E, Roscioni S, Ussar S, Feuchtinger A, Yesildag B, Neelakandhan A, Jensen CB, Cornu M, Yang B, Finan B, DiMarchi RD, Tschöp MH, Theis FJ, Hofmann SM, Müller TD, Lickert H. Sachs S, et al. Nat Metab. 2020 Feb;2(2):192-209. doi: 10.1038/s42255-020-0171-3. Epub 2020 Feb 20. Nat Metab. 2020. PMID: 32694693
Publication types
LinkOut - more resources
Full Text Sources